Correction to: Nature https://doi.org/10.1038/s41586-022-04439-0 Published online 23 February 2022
In the version of this article initially published, there were labeling errors in Fig. 1a. In the top-left, bright green “Anti-HER2” section, the top peptide node now labeled “VH-3” initially appeared as “VL-3.” In the top-middle blue “Anti-CD3” section, the lower node now labeled “VH-2” initially appeared as “VL-2.” In the top-right olive “Anti-CD28” section, the top node now labeled “VH-1” and the lower node now labeled “VL-1” initially appeared as “VL-1” and “VL-3,” respectively. The changes have been made to the HTML and PDF versions of the article
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Seung, E., Xing, Z., Wu, L. et al. Publisher Correction: A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells. Nature 604, E13 (2022). https://doi.org/10.1038/s41586-022-04652-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-022-04652-x
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.